Recent Blog Articles
Thinking about COVID booster shots? Here’s what to know
Cancer survivors' sleep is affected long after treatment
Do I have to yell so much?
What to do when elective surgery is postponed
What happened to trusting medical experts?
Stuttering in children: How parents can help
Icy fingers and toes: Poor circulation or Raynaud’s phenomenon?
Evoking calm: Practicing mindfulness in daily life helps
Finding balance: 3 simple exercises to steady your steps
Boosting your child’s immune system
Promising results for a targeted drug in advanced prostate cancer
- By Charlie Schmidt, Editor, Harvard Medical School Annual Report on Prostate Diseases
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
thanks from your site and Beneficial Articles.
pls connect me to a letter about cancer treatment with
nano gold particles.
is this testing available now to anyone?
Hi Charles, thanks for getting this blog out. Interesting conclusion of the study.. “Treatment with the PARP inhibitor olaparib in patients whose prostate cancers were no longer responding to standard treatments and who had defects in DNA-repair genes led to a high response rate.” This is a field that we will be paying more attention to later.
Commenting has been closed for this post.
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!